Hepatitis C SIG
Brian L. Pearlman, MD, FAASLDPreeti A. Reshamwala, MDJean-Michel Pawlotsky, MD, PhD, FAASLD
Omar Massoud, MD, PhD, FAASLD
Many HCV-infected patients suffer from decompensated cirrhosis. Aside from appropriate care of their cirrhosis, these patients may benefit from therapy, irrespective of liver transplant candidacy. Providers outside of transplant centers, should be knowledgeable about pertinent aspects of liver transplants for their patients. Finally, several groups have reported unusual genotype subtypes which are less responsive to existing DAA regimens. This webinar is designed for the experienced HCV-treatment provider.